Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2004Expert Review of Anticancer Therapy

Anticancer drug development based on modulation of the Bcl-2 family core apoptosis mechanism

View Full Paper
Ask AI
Bookmark
Share

Authors

CGColin GardnerUniversity of Georgia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Colin Gardner (2004) studied this question.

synapsesocial.com/papers/6aa417155b75cc9dd9c97993https://doi.org/10.1586/14737140.4.6.1157
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis2003 · 821 citations
  2. 2BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death2000 · 432 citations
  3. 3Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers2000 · 40 citations
  4. 4Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents2002 · 176 citations